Trials / Completed
CompletedNCT03509467
Using MC1R Genotype to Impact Melanoma Risk Behavior
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 2,054 (actual)
- Sponsor
- H. Lee Moffitt Cancer Center and Research Institute · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to examine how different messages about risk of melanoma can impact the way people protect themselves against developing these diseases.
Conditions
- Melanoma (Skin)
- Squamous Cell Carcinoma
- Squamous Cell Cancer
- Skin Cancer
- Basal Cell Carcinoma
- Basal Cell Cancer
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Personalized Information | Personalized information about ways that participants can protect themselves and their child from developing melanoma. |
| BEHAVIORAL | Standard Information | Standard information about ways that participants can protect themselves and their child from developing melanoma. |
| OTHER | DNA Extraction Determination of MC1R Genotypes | After signing informed consent, a biologic sample (saliva) will be collected for the purpose of DNA extraction determination of MC1R genotypes. All participants who carry high risk MC1R genotypes and a proportion of those who carry low risk or no MC1R variants will be randomized to the control or intervention arm. |
Timeline
- Start date
- 2015-08-03
- Primary completion
- 2021-02-19
- Completion
- 2021-02-19
- First posted
- 2018-04-26
- Last updated
- 2025-12-19
- Results posted
- 2023-11-21
Locations
2 sites across 2 countries: United States, Puerto Rico
Source: ClinicalTrials.gov record NCT03509467. Inclusion in this directory is not an endorsement.